AMERESCO INC-CL A (AMRC)

US02361E1082 - Common Stock

27.51  +2.37 (+9.43%)

After market: 27.625 +0.11 (+0.42%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to AMRC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 38.3. This target is 39.21% above the current price.
AMRC was analyzed by 20 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about AMRC.
In the previous month the buy percentage consensus was at a similar level.
AMRC was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 27.5128.2838.7638.3045.15 - 2.80% 40.89% 39.21% 64.12%
Up and Down Grades
Date Firm Action Rating
2024-11-11 Stifel Maintains Buy -> Buy
2024-10-22 Piper Sandler Maintains Overweight -> Overweight
2024-09-23 Baird Maintains Outperform -> Outperform
2024-09-05 UBS Maintains Buy -> Buy
2024-09-04 Jefferies Initiate Hold
2024-08-27 Baird Maintains Outperform -> Outperform
2024-08-06 Piper Sandler Maintains Overweight -> Overweight
2024-07-22 Piper Sandler Maintains Overweight -> Overweight
2024-05-14 UBS Maintains Buy -> Buy
2024-05-09 Stifel Maintains Buy -> Buy
2024-05-09 Baird Maintains Outperform -> Outperform
2024-04-22 Truist Securities Maintains Buy -> Buy
2024-04-17 Oppenheimer Maintains Perform -> Perform
2024-04-11 Piper Sandler Maintains Overweight -> Overweight
2024-04-03 Raymond James Maintains Outperform -> Outperform
2024-03-12 Exane BNP Paribas Upgrade Neutral -> Outperform
2024-03-05 Piper Sandler Maintains Overweight -> Overweight
2024-02-29 Canaccord Genuity Maintains Buy -> Buy
2024-02-05 B. Riley Securities Maintains Buy -> Buy
2023-12-15 B of A Securities Downgrade Buy -> Neutral
2023-11-08 Stifel Maintains Buy -> Buy
2023-11-07 William Blair Downgrade Outperform -> Market Perform
2023-11-07 Oppenheimer Downgrade Outperform -> Perform
2023-11-07 Raymond James Maintains Outperform -> Outperform
2023-10-25 Roth MKM Upgrade Neutral -> Buy
2023-10-20 Exane BNP Paribas Initiate Neutral
2023-10-12 Oppenheimer Maintains Outperform -> Outperform
2023-10-06 Piper Sandler Maintains Overweight -> Overweight
2023-10-03 Raymond James Maintains Outperform -> Outperform
2023-08-01 Oppenheimer Maintains Outperform -> Outperform